276 related articles for article (PubMed ID: 28234688)
1. Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis, and Adverse Perinatal Outcomes in HIV Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
Hernández S; Catalán-García M; Morén C; García-Otero L; López M; Guitart-Mampel M; Milisenda J; Coll O; Cardellach F; Gratacós E; Miró Ò; Garrabou G
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):e113-e119. PubMed ID: 28234688
[TBL] [Abstract][Full Text] [Related]
2. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
[TBL] [Abstract][Full Text] [Related]
3. Imbalance in mitochondrial dynamics and apoptosis in pregnancies among HIV-infected women on HAART with obstetric complications.
Guitart-Mampel M; Hernandez AS; Moren C; Catalan-Garcia M; Tobias E; Gonzalez-Casacuberta I; Juarez-Flores DL; Gatell JM; Cardellach F; Milisenda JC; Grau JM; Gratacos E; Figueras F; Garrabou G
J Antimicrob Chemother; 2017 Sep; 72(9):2578-2586. PubMed ID: 28859443
[TBL] [Abstract][Full Text] [Related]
4. Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress.
Ross AC; Leong T; Avery A; Castillo-Duran M; Bonilla H; Lebrecht D; Walker UA; Storer N; Labbato D; Khaitan A; Tomanova-Soltys I; McComsey GA
HIV Med; 2012 Feb; 13(2):98-106. PubMed ID: 22103263
[TBL] [Abstract][Full Text] [Related]
5. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.
Poirier MC; Divi RL; Al-Harthi L; Olivero OA; Nguyen V; Walker B; Landay AL; Walker VE; Charurat M; Blattner WA;
J Acquir Immune Defic Syndr; 2003 Jun; 33(2):175-83. PubMed ID: 12794551
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.
Aldrovandi GM; Chu C; Shearer WT; Li D; Walter J; Thompson B; McIntosh K; Foca M; Meyer WA; Ha BF; Rich KC; Moye J
Pediatrics; 2009 Dec; 124(6):e1189-97. PubMed ID: 19933732
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.
Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA
Antivir Ther; 2009; 14(3):331-8. PubMed ID: 19474467
[TBL] [Abstract][Full Text] [Related]
8. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
Sebitloane HM; Moodley J
Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
[TBL] [Abstract][Full Text] [Related]
9. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
Mofenson LM;
MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
[TBL] [Abstract][Full Text] [Related]
10. Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy.
Poirier MC; Gibbons AT; Rugeles MT; Andre-Schmutz I; Blanche S
Curr Opin Pediatr; 2015 Apr; 27(2):233-9. PubMed ID: 25635584
[TBL] [Abstract][Full Text] [Related]
11. Elevated Levels of Estradiol in Human Immunodeficiency Virus-Infected Pregnant Women on Protease Inhibitor-Based Regimens.
Balogun KA; Guzman Lenis MS; Papp E; Loutfy M; Yudin MH; MacGillivray J; Walmsley SL; Silverman M; Serghides L
Clin Infect Dis; 2018 Jan; 66(3):420-427. PubMed ID: 29020282
[TBL] [Abstract][Full Text] [Related]
12. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
Kowalska A; Niemiec T; El Midaoui A; Burkacka E
Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
[TBL] [Abstract][Full Text] [Related]
13. Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy.
Shiramizu B; Shikuma KM; Kamemoto L; Gerschenson M; Erdem G; Pinti M; Cossarizza A; Shikuma C
J Acquir Immune Defic Syndr; 2003 Apr; 32(4):370-4. PubMed ID: 12640193
[TBL] [Abstract][Full Text] [Related]
14. Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
Ajaykumar A; Zhu M; Kakkar F; Brophy J; Bitnun A; Alimenti A; Soudeyns H; Saberi S; Albert AYK; Money DM; Côté HCF;
J Infect Dis; 2021 Feb; 223(4):621-631. PubMed ID: 32638023
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
16. Protease inhibitor treatment in HIV pregnant women. Is it safe for newborns?
García-Tejedor A; Perales A; Maiques V
Int J Gynaecol Obstet; 2002 Feb; 76(2):175-6. PubMed ID: 11818114
[No Abstract] [Full Text] [Related]
17. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
[TBL] [Abstract][Full Text] [Related]
18. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
Thorne C; Newell ML
Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
[TBL] [Abstract][Full Text] [Related]
19. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
Thorne C; Newell ML
Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
[TBL] [Abstract][Full Text] [Related]
20. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
